BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jones DE. Autoantigens in primary biliary cirrhosis. J Clin Pathol. 2000;53:813-821. [PMID: 11127262 DOI: 10.1136/jcp.53.11.813] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Haruta I, Kikuchi K, Nakamura M, Hirota K, Kato H, Miyakawa H, Shibata N, Miyake Y, Hashimoto E, Shiratori K, Yagi J. Involvement of commensal bacteria may lead to dysregulated inflammatory and autoimmune responses in a mouse model for chronic nonsuppurative destructive cholangitis. J Clin Immunol 2012;32:1026-37. [PMID: 22661269 DOI: 10.1007/s10875-012-9712-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
2 Damoiseaux J, Andrade LE, Fritzler MJ, Shoenfeld Y. Autoantibodies 2015: From diagnostic biomarkers toward prediction, prognosis and prevention. Autoimmun Rev 2015;14:555-63. [PMID: 25661979 DOI: 10.1016/j.autrev.2015.01.017] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 7.6] [Reference Citation Analysis]
3 Hazama H, Omagari K, Masuda J, Ohba K, Kinoshita H, Matsuo I, Isomoto H, Mizuta Y, Murase K, Murata I, Kohno S. Automated enzymatic mitochondrial antibody assay for the diagnosis of primary biliary cirrhosis: Applications of a routine diagnostic tool for the detection of antimitochondrial antibodies. J Gastroenterol Hepatol 2002;17:316-23. [DOI: 10.1046/j.1440-1746.2002.02700.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
4 Pelka K, Stec-Polak M, Wojas-Pelc A, Pastuszczak M. Prevalence of antimitochondrial antibodies in subacute cutaneous lupus erythematosus. Int J Dermatol 2021;60:88-92. [PMID: 33017043 DOI: 10.1111/ijd.15225] [Reference Citation Analysis]
5 Etxagibel A, Julià MR, Brotons A, Company MM, Dolz C. Drug-induced hepatitis superimposed on the presence of anti-SLA antibody: a case report. J Med Case Rep. 2008;2:25. [PMID: 18226219 DOI: 10.1186/1752-1947-2-25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Jiang XH, Zhong RQ, Fan XY, Hu Y, An F, Sun JW, Kong XT. Characterization of M2 antibodies in asymptomatic Chinese population. World J Gastroenterol 2003; 9(9): 2128-2131 [PMID: 12970922 DOI: 10.3748/wjg.v9.i9.2128] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
7 Gabeta S, Norman GL, Liaskos C, Papamichalis PA, Zografos T, Garagounis A, Rigopoulou EI, Dalekos GN. Diagnostic relevance and clinical significance of the new enhanced performance M2 (MIT3) ELISA for the detection of IgA and IgG antimitochondrial antibodies in primary biliary cirrhosis. J Clin Immunol 2007;27:378-87. [PMID: 17514501 DOI: 10.1007/s10875-007-9092-0] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
8 Jiang T, Han Z, Chen S, Wu C, Tang Y, Qian C, Chen Y, Zhou Y, Zhu Y, Gu M. Resistance to activation-induced cell death and elevated FLIPL expression of CD4+ T cells in a polyI:C-induced primary biliary cirrhosis mouse model. Clin Exp Med. 2009;9:269-276. [PMID: 19418018 DOI: 10.1007/s10238-009-0052-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
9 Niwa M, Fukuoka K, Fujimoto T, Maruyama IN. Efficient isolation of cDNA clones encoding rheumatoid arthritis autoantigens by lambda phage surface display. J Biotechnol 2004;114:55-8. [PMID: 15464598 DOI: 10.1016/j.jbiotec.2004.05.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
10 Wunsch E, Post M, Gutkowski K, Marlicz W, Szymanik B, Hartleb M, Milkiewicz P. Critical flicker frequency fails to disclose brain dysfunction in patients with primary biliary cirrhosis. Dig Liver Dis 2010;42:818-21. [PMID: 20430705 DOI: 10.1016/j.dld.2010.03.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
11 Masuda J, Omagari K, Ohba K, Hazama H, Kadokawa Y, Kinoshita H, Hayashida K, Hayashida K, Ishibashi H, Nakanuma Y, Kohno S. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis. Dig Dis Sci 2003;48:932-8. [PMID: 12772793 DOI: 10.1023/a:1023055714208] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Hawa M, Beyan H, Leslie R. Principles of Autoantibodies as Disease-specific Markers. Autoimmunity 2009;37:253-6. [DOI: 10.1080/08916930410001710668] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
13 Li CH, Xu PS, Wang CY, Zhang Y, Zou GL. The presence of anti-mitochondrial antibodies in Chinese patients with liver involvement in systemic lupus erythematosus. Rheumatol Int 2006;26:697-703. [PMID: 16609870 DOI: 10.1007/s00296-005-0034-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
14 Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J, Guidi M, Ferri S, DE Molo C, Lenzi M. Antinuclear antibodies giving the ‘multiple nuclear dots’ or the ‘rim-like/membranous’ patterns: diagnostic accuracy for primary biliary cirrhosis. Aliment Pharmacol Ther. 2006;24:1575-1583. [PMID: 17206945 DOI: 10.1111/j.1365-2036.2006.03172.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
15 Krysko DV, Agostinis P, Krysko O, Garg AD, Bachert C, Lambrecht BN, Vandenabeele P. Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 2011;32:157-64. [PMID: 21334975 DOI: 10.1016/j.it.2011.01.005] [Cited by in Crossref: 396] [Cited by in F6Publishing: 394] [Article Influence: 36.0] [Reference Citation Analysis]
16 Nissinen R, Paimela L, Julkunen H, Tienari PJ, Leirisalo-Repo M, Palosuo T, Vaarala O. Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sjögren syndrome. Scand J Rheumatol 2003;32:337-42. [PMID: 15080264 DOI: 10.1080/03009740410004990] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
17 Farias AQ, Goncalves LL, Bittencourt PL, De Melo ES, Abrantes-lemos CP, Porta G, Nakhle MC, Carrilho FJ, Cancado ELR. Applicability of the IAIHG scoring system to the diagnosis of antimitochondrial/anti-M2 seropositive variant form of autoimmune hepatitis. J Gastroenterol Hepatol 2006;21:887-93. [DOI: 10.1111/j.1440-1746.2006.04130.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.7] [Reference Citation Analysis]
18 Grignolio A, Mishto M, Faria AM, Garagnani P, Franceschi C, Tieri P. Towards a liquid self: how time, geography, and life experiences reshape the biological identity. Front Immunol. 2014;5:153. [PMID: 24782860 DOI: 10.3389/fimmu.2014.00153] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
19 Li C, Xu P, Wang C, Zou G. Increased serum aminotransferases associated with anti-mitochondrial antibodies in systemic lupus erythematosus patients with autoimmune liver disease. Clinica Chimica Acta 2006;365:135-42. [DOI: 10.1016/j.cca.2005.08.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
20 Jiang XH, Zhong RQ, Yu SQ, Hu Y, Li WW, Kong XT. Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis. World J Gastroenterol 2003; 9(6): 1352-1355 [PMID: 12800255 DOI: 10.3748/wjg.v9.i6.1352] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
21 Newton JL. Fatigue in primary biliary cirrhosis. Clin Liver Dis. 2008;12:367-83; ix. [PMID: 18456186 DOI: 10.1016/j.cld.2008.02.010] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
22 Aibara N, Ohyama K, Nakamura M, Nakamura H, Tamai M, Kishikawa N, Kawakami A, Tsukamoto K, Nakashima M, Kuroda N. Investigation of immune complexes formed by mitochondrial antigens containing a new lipoylated site in sera of primary biliary cholangitis patients. Clin Exp Immunol 2021;204:335-43. [PMID: 33605437 DOI: 10.1111/cei.13588] [Reference Citation Analysis]
23 Golla K, Epstein JB, Cabay RJ. Liver disease: Current perspectives on medical and dental management. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2004;98:516-21. [DOI: 10.1016/j.tripleo.2004.09.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
24 Jones DE. Pathogenesis of primary biliary cirrhosis. J Hepatol. 2003;39:639-648. [PMID: 12971978 DOI: 10.1016/s0168-8278(03)00270-8] [Cited by in Crossref: 40] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
25 Nakamura T, Shirouzu T. Antibody-Mediated Rejection and Recurrent Primary Disease: Two Main Obstacles in Abdominal Kidney, Liver, and Pancreas Transplants. J Clin Med 2021;10:5417. [PMID: 34830699 DOI: 10.3390/jcm10225417] [Reference Citation Analysis]
26 Bauer A, Habior A. Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis. J Clin Lab Anal. 2007;21:227-231. [PMID: 17621358 DOI: 10.1002/jcla.20170] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]